- Home
- CMTL vs CRVO Comparison
CMTL vs CRVO Comparison
Compare CMTL & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMTL
- CRVO
- Stock Information
- Founded
- CMTL 1967
- CRVO 2001
- Country
- CMTL United States
- CRVO United States
- Employees
- CMTL N/A
- CRVO N/A
- Industry
- CMTL Radio And Television Broadcasting And Communications Equipment
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- CMTL Technology
- CRVO Health Care
- Exchange
- CMTL Nasdaq
- CRVO Nasdaq
- Market Cap
- CMTL 97.9M
- CRVO 98.3M
- IPO Year
- CMTL N/A
- CRVO N/A
- Fundamental
- Price
- CMTL $3.51
- CRVO $1.95
- Analyst Decision
- CMTL Strong Buy
- CRVO Buy
- Analyst Count
- CMTL 1
- CRVO 8
- Target Price
- CMTL $9.25
- CRVO $38.75
- AVG Volume (30 Days)
- CMTL 363.6K
- CRVO 922.0K
- Earning Date
- CMTL 12-24-2024
- CRVO 11-12-2024
- Dividend Yield
- CMTL N/A
- CRVO N/A
- EPS Growth
- CMTL N/A
- CRVO N/A
- EPS
- CMTL N/A
- CRVO N/A
- Revenue
- CMTL $540,403,000.00
- CRVO $10,066,550.00
- Revenue This Year
- CMTL $0.96
- CRVO $34.17
- Revenue Next Year
- CMTL $10.66
- CRVO N/A
- P/E Ratio
- CMTL N/A
- CRVO N/A
- Revenue Growth
- CMTL N/A
- CRVO 116.29
- 52 Week Low
- CMTL $1.53
- CRVO $1.80
- 52 Week High
- CMTL $8.71
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- CMTL 53.48
- CRVO 24.32
- Support Level
- CMTL $2.73
- CRVO $1.80
- Resistance Level
- CMTL $3.77
- CRVO $2.10
- Average True Range (ATR)
- CMTL 0.30
- CRVO 1.45
- MACD
- CMTL -0.01
- CRVO -0.64
- Stochastic Oscillator
- CMTL 61.52
- CRVO 0.95
About CMTL Comtech Telecommunications Corp.
Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.